Circulation, Vol 83, 1615-1620, Copyright © 1991 by American Heart Association
TF Christian, IP Clements and RJ Gibbons
BACKGROUND. Patients who have chest pain without electrocardiographic ST
elevation are not candidates for thrombolytic therapy in most clinical
trials. This study examined the value of technetium-99m- Sestamibi
tomographic imaging to assess myocardial perfusion in patients during chest
pain without ST elevation. METHODS AND RESULTS. Tc-99m-Sestamibi was
injected in 14 patients who had chest pain without ST elevation, who
subsequently developed enzymatic evidence of myocardial infarction within
24 hours. Tomographic imaging was performed 1-6 hours after injection.
Thirteen of 14 patients showed significant perfusion defects indicative of
acute myocardial infarction consistent with absent perfusion (20 +/- 15% of
the left ventricle; range, 2-53%); one patient had normal images. Because
of the absence of definitive electrocardiographic changes, only five
patients received reperfusion therapy within 6 hours of the onset of chest
pain. Regional wall motion abnormalities were present in nine of nine
patients undergoing contrast ventriculography and correlated with the
location of the Tc-99m-Sestamibi perfusion defect. At the time of
subsequent coronary angiography, total arterial occlusion was present in 11
of the 14 patients. The infarct-related artery could be identified in 13 of
the 14 patients. In six of these 13 patients, the left circumflex was the
infarct-related artery. CONCLUSIONS. Patients who have chest pain without
electrocardiographic ST elevation may have arterial occlusion and
significant myocardium at risk. Tc-99m-Sestamibi imaging may be of benefit
in identifying these patients early so that they can be considered for
acute reperfusion therapy.
ARTICLES
Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m-Sestamibi
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn. 55905.
This article has been cited by other articles:
![]() |
J E Udelson and E J Flint Radionuclide imaging in risk assessment after acute coronary syndromes Heart, August 1, 2004; 90(suppl_5): v16 - v25. [Full Text] [PDF] |
||||
![]() |
I. Matsunari, U. Schricke, F. M. Bengel, H.-U. Haase, P. Barthel, G. Schmidt, S. G. Nekolla, A. Schoemig, and M. Schwaiger Extent of Cardiac Sympathetic Neuronal Damage Is Determined by the Area of Ischemia in Patients With Acute Coronary Syndromes Circulation, June 6, 2000; 101(22): 2579 - 2585. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |